Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study. (Q52869895)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 February 2015

Language	Label	Description	Also known as
English	Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.	scientific article published on 6 February 2015

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

Martin Feuchtenberger

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Stefan Kleinert

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Hans-Peter Tony

8

object named as

Hans-Peter Tony

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

24

object named as

Juergen Rech

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Stephanie Finzel

7

object named as

Stephanie Finzel

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Matthias Englbrecht

2

object named as

Matthias Englbrecht

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

object named as

Judith Haschka

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Bernhard Manger

4

object named as

Bernhard Manger

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

5

object named as

Arnd Kleyer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Michaela Reiser

6

object named as

Michaela Reiser

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

15

object named as

Joerg Wendler

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Monika Ronneberger

17

object named as

Monika Ronneberger

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

12

object named as

Karin Manger

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Matthias Schmitt-Haendle

14

object named as

Matthias Schmitt-Haendle

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Hanns-Martin Lorenz

18

object named as

Hanns-Martin Lorenz

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Hubert Nuesslein

19

object named as

Hubert Nuesslein

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

20

object named as

Rieke Alten

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

22

object named as

Joerg Henes

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Martin Fleck

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Wolfgang Ochs

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Florian Schuch

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Winfried Demary

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Georg Schett

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

0 references

publication date

6 February 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

75

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

45-51

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25660991%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

The pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Treating rheumatoid arthritis to target: recommendations of an international task force

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Sustained rheumatoid arthritis remission is uncommon in clinical practice

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

D-penicillamine withdrawal in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Effect of discontinuing TNFalpha antagonist therapy in patients with remission of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Sustained clinical remission and rate of relapse after tocilizumab withdrawal in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

When to initiate and discontinue biologic treatments for rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Withdrawal of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Drug-free remission: is it already possible?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: Results from two large early arthritis cohorts

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206439

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52869895&oldid=1743992350"